296 related articles for article (PubMed ID: 26762378)
1. Effects of propranolol on conversational reciprocity in autism spectrum disorder: a pilot, double-blind, single-dose psychopharmacological challenge study.
Zamzow RM; Ferguson BJ; Stichter JP; Porges EC; Ragsdale AS; Lewis ML; Beversdorf DQ
Psychopharmacology (Berl); 2016 Apr; 233(7):1171-8. PubMed ID: 26762378
[TBL] [Abstract][Full Text] [Related]
2. Effects of acute beta-adrenergic antagonism on verbal problem solving in autism spectrum disorder and exploration of treatment response markers.
Zamzow RM; Ferguson BJ; Ragsdale AS; Lewis ML; Beversdorf DQ
J Clin Exp Neuropsychol; 2017 Aug; 39(6):596-606. PubMed ID: 27841098
[TBL] [Abstract][Full Text] [Related]
3. Propranolol for treating emotional, behavioural, autonomic dysregulation in children and adolescents with autism spectrum disorders.
Sagar-Ouriaghli I; Lievesley K; Santosh PJ
J Psychopharmacol; 2018 Jun; 32(6):641-653. PubMed ID: 29484909
[TBL] [Abstract][Full Text] [Related]
4. Effect of propranolol on facial scanning in autism spectrum disorder: a preliminary investigation.
Zamzow RM; Christ SE; Saklayen SS; Moffitt AJ; Bodner KE; Higgins KF; Beversdorf DQ
J Clin Exp Neuropsychol; 2014; 36(4):431-45. PubMed ID: 24730708
[TBL] [Abstract][Full Text] [Related]
5. Beta-adrenergic antagonism modulates functional connectivity in the default mode network of individuals with and without autism spectrum disorder.
Hegarty JP; Ferguson BJ; Zamzow RM; Rohowetz LJ; Johnson JD; Christ SE; Beversdorf DQ
Brain Imaging Behav; 2017 Oct; 11(5):1278-1289. PubMed ID: 27714553
[TBL] [Abstract][Full Text] [Related]
6.
Hegarty JP; Zamzow RM; Ferguson BJ; Christ SE; Porges EC; Johnson JD; Beversdorf DQ
Autism; 2020 Apr; 24(3):795-801. PubMed ID: 31416333
[No Abstract] [Full Text] [Related]
7. Effect of propranolol on hypertonic saline-evoked masseter muscle pain and autonomic response in healthy women during rest and mental arithmetic task.
Bendixen KH; Terkelsen AJ; Baad-Hansen L; Cairns BE; Svensson P
J Orofac Pain; 2013; 27(3):243-55. PubMed ID: 23882457
[TBL] [Abstract][Full Text] [Related]
8. Noradrenergic moderation of working memory impairments in adults with autism spectrum disorder.
Bodner KE; Beversdorf DQ; Saklayen SS; Christ SE
J Int Neuropsychol Soc; 2012 May; 18(3):556-64. PubMed ID: 22414705
[TBL] [Abstract][Full Text] [Related]
9. Randomized controlled trial of propranolol on social communication and anxiety in children and young adults with autism spectrum disorder.
Beversdorf DQ; Ferguson B; Hunter S; Hirst K; Lolli B; Bellesheim KR; Barton AU; Muckerman J; Takahashi N; Selders K; Holem R; Sohl K; Dyke P; Stichter J; Mazurek M; Kanne S
Psychopharmacology (Berl); 2024 Jan; 241(1):19-32. PubMed ID: 38086927
[TBL] [Abstract][Full Text] [Related]
10. An investigation of the effect of social reciprocity, social anxiety, and letter fluency on communicative behaviors in adults with autism spectrum disorder.
Kimura Y; Fujioka T; Jung M; Fujisawa TX; Tomoda A; Kosaka H
Psychiatry Res; 2020 Dec; 294():113503. PubMed ID: 33113450
[TBL] [Abstract][Full Text] [Related]
11. Effect of propranolol on verbal problem solving in autism spectrum disorder.
Beversdorf DQ; Carpenter AL; Miller RF; Cios JS; Hillier A
Neurocase; 2008; 14(4):378-83. PubMed ID: 18766980
[TBL] [Abstract][Full Text] [Related]
12. Brief Report: Intranasal Ketamine in Adolescents and Young Adults with Autism Spectrum Disorder-Initial Results of a Randomized, Controlled, Crossover, Pilot Study.
Wink LK; Reisinger DL; Horn P; Shaffer RC; O'Brien K; Schmitt L; Dominick KR; Pedapati EV; Erickson CA
J Autism Dev Disord; 2021 Apr; 51(4):1392-1399. PubMed ID: 32642957
[TBL] [Abstract][Full Text] [Related]
13. Beta receptor-mediated modulation of the oddball P3 but not error-related ERP components in humans.
de Rover M; Brown SB; Band GP; Giltay EJ; van Noorden MS; van der Wee NJ; Nieuwenhuis S
Psychopharmacology (Berl); 2015 Sep; 232(17):3161-72. PubMed ID: 26138780
[TBL] [Abstract][Full Text] [Related]
14. Dose-dependent social-cognitive effects of intranasal oxytocin delivered with novel Breath Powered device in adults with autism spectrum disorder: a randomized placebo-controlled double-blind crossover trial.
Quintana DS; Westlye LT; Hope S; Nærland T; Elvsåshagen T; Dørum E; Rustan Ø; Valstad M; Rezvaya L; Lishaugen H; Stensønes E; Yaqub S; Smerud KT; Mahmoud RA; Djupesland PG; Andreassen OA
Transl Psychiatry; 2017 May; 7(5):e1136. PubMed ID: 28534875
[TBL] [Abstract][Full Text] [Related]
15. Clinical and neural effects of six-week administration of oxytocin on core symptoms of autism.
Watanabe T; Kuroda M; Kuwabara H; Aoki Y; Iwashiro N; Tatsunobu N; Takao H; Nippashi Y; Kawakubo Y; Kunimatsu A; Kasai K; Yamasue H
Brain; 2015 Nov; 138(Pt 11):3400-12. PubMed ID: 26336909
[TBL] [Abstract][Full Text] [Related]
16. Effect of propranolol on functional connectivity in autism spectrum disorder--a pilot study.
Narayanan A; White CA; Saklayen S; Scaduto MJ; Carpenter AL; Abduljalil A; Schmalbrock P; Beversdorf DQ
Brain Imaging Behav; 2010 Jun; 4(2):189-97. PubMed ID: 20502989
[TBL] [Abstract][Full Text] [Related]
17. Modified CBT using visualization for Autism Spectrum Disorder (ASD), anxiety and avoidance behavior--a quasi-experimental open pilot study.
Ekman E; Hiltunen AJ
Scand J Psychol; 2015 Dec; 56(6):641-8. PubMed ID: 26565732
[TBL] [Abstract][Full Text] [Related]
18. Propranolol reduces the anxiety associated with day case surgery.
Mealy K; Ngeh N; Gillen P; Fitzpatrick G; Keane FB; Tanner A
Eur J Surg; 1996 Jan; 162(1):11-4. PubMed ID: 8679756
[TBL] [Abstract][Full Text] [Related]
19. A Single Dose, Randomized, Controlled Proof-Of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder.
Umbricht D; Del Valle Rubido M; Hollander E; McCracken JT; Shic F; Scahill L; Noeldeke J; Boak L; Khwaja O; Squassante L; Grundschober C; Kletzl H; Fontoura P
Neuropsychopharmacology; 2017 Aug; 42(9):1914-1923. PubMed ID: 27711048
[TBL] [Abstract][Full Text] [Related]
20. The Role of the Noradrenergic System in Autism Spectrum Disorders, Implications for Treatment.
Beversdorf DQ
Semin Pediatr Neurol; 2020 Oct; 35():100834. PubMed ID: 32892961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
